Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines

There are limited pharmacokinetic data for use of the first-line antituberculosis drugs during infancy (<12 months of age), when drug disposition may differ. Intensive pharmacokinetic sampling was performed in infants routinely receiving antituberculosis treatment, including rifampin, isoniazid,...

Full description

Saved in:

Bibliographic Details
Published in:	Antimicrob Agents Chemother
Main Authors:	Bekker, A., Schaaf, H. S., Draper, H. R., van der Laan, L., Murray, S., Wiesner, L., Donald, P. R., McIlleron, H. M., Hesseling, A. C.
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology 2016
Subjects:	Pharmacology
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4808214/ https://ncbi.nlm.nih.gov/pubmed/26810651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02600-15
Tags:	Add Tag No Tags, Be the first to tag this record!

Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines

Similar Items